ROS, E. O. “The US FDA-Approved Drug Dimethyl Fumarate, an Nrf2 Activator, for Treating Multiple Sclerosis: The Mechanisms of Action Revisited”. Reactive Oxygen Species, vol. 11, Feb. 2021, pp. n7–n8, doi:10.20455/ros.2021.n.807.